INSM-18

Thuốc Gốc

Small Molecule

INSM-18 is a small molecule tyrosine kinase inhibitor developed by Insmed for the treatment of prostate cancer.

Cơ Chế Tác Dụng : INSM-18 is a small molecule tyrosine kinase inhibitor developed by Insmed for the treatment of prostate cancer. INSM-18 shows selective inhibition of the insulin-like factor-I receptor (IGF-1) and human epidermal growth factor receptor, Her2/neu. These results suggest the molecule has enormous potential to eventually treat the 230,000 new cases of prostate cancer that occur every year in the United States.

Chỉ Định : Investigated for use/treatment in prostate cancer.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05900

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading